The DOI matches its Crossref record; 198 of the 199 references it cites were found in a registry or an index.
The P2X7 Receptor in Infection and Inflammation
Open accessAbstract
Adenosine triphosphate (ATP) accumulates at sites of tissue injury and inflammation. Effects of extracellular ATP are mediated by plasma membrane receptors named P2 receptors (P2Rs). The P2R most involved in inflammation and immunity is the P2X7 receptor (P2X7R), expressed by virtually all cells of innate and adaptive immunity. P2X7R mediates NLRP3 inflammasome activation, cytokine and chemokine release, T lymphocyte survival and differentiation, transcription factor activation, and cell death. Ten human P2RX7 gene splice variants and several SNPs that produce complex haplotypes are known. The P2X7R is a potent stimulant of inflammation and immunity and a promoter of cancer cell growth. This makes P2X7R an appealing target for anti-inflammatory and anti-cancer therapy. However, an in-depth knowledge of its structure and of the associated signal transduction mechanisms is needed for an effective therapeutic development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“P2X7, which is widely expressed by immune cells, is the most studied purinergic receptors involved in neurodegeneration.374,375”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [374]
Experimental — accuracy not yet measuredIn the citing paper
“Hyperactivation of P2X7 receptors is closely related to inflammatory processes since they are stimulated by ATP released from distressed cells and induce inflammasome activation [16–18].”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [16]
In the citing paper
“In these circumstances, ATP may act as DAMP, which activates the nuclear transcription factor NF-κB resulting in expression upregulation of pro-IL-1β and pro-IL-18 and the NLRP3 protein [16, 71].”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [16]
In the citing paper
“Consequently, there is an activation of caspase-1 and maturation of IL-1β and IL-18, resulting in pro-inflammatory cytokine release [16, 20, 52, 71, 73].”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [16]
In the citing paper
“The P2X7 receptor is a major activator of the NLRP3 inflammasome in several cell types [16], including macrophages and microglial cells [72, 74–76].”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [16]
In the citing paper
“In fact, the role of P2X7 receptor as a modulator of inflammatory response is well-established [16, 70].”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [16]
In the citing paper
“The massive ATP release following lung mononuclear phagocytes invasion by SARS-CoV-2 can activate P2X7 receptors of antigen-presenting cells and macrophages, increasing cytokine, chemokine and ATP secretion [16].”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [16]
In the citing paper
“As discussed by Di Virgilio et al. [106], many processes associated with lung impairment, as seen in COVID-19 patients, are mediated by P2X7 receptors [16].”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
Shi, J., Zhao, Y., Wang, K., Shi, X., Wang, Y., Huang, H., Zhuang, Y., Cai, T., Wang, F., & Shao, F. (2015) · Nature · doi:10.1038/nature15514 · Cited by 6,659
Martinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066
Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling
Kayagaki, N., Stowe, I. B., Lee, B. L., O’Rourke, K., Anderson, K., Warming, S., Cuellar, T., Haley, B., Roose-Girma, M., Phung, Q. T., et al. (2015) · Nature · doi:10.1038/nature15541 · Cited by 3,686
Immunogenic Cell Death in Cancer Therapy
Kroemer, G., Galluzzi, L., Kepp, O., & Zitvogel, L. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-100008 · Cited by 3,303
Calreticulin exposure dictates the immunogenicity of cancer cell death
Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1523 · Cited by 3,216
Immunogenic cell death in cancer and infectious disease
Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., & Kroemer, G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.107 · Cited by 3,119
Functional Polarization of Tumour-Associated Macrophages by Tumour-Derived Lactic Acid
Colegio, O. R., Chu, N.-Q., Szabo, A. L., Chu, T., Rhebergen, A. M., Jairam, V., Cyrus, N., Brokowski, C. E., Eisenbarth, S. C., Phillips, G. M., et al. (2014) · Nature · doi:10.1038/nature13490 · Cited by 3,046
Molecular Physiology of P2X Receptors
North, R. A. (2002) · Physiological Reviews · doi:10.1152/physrev.00015.2002 · Cited by 2,919
Muñoz-Planillo, R., Kuffa, P., Martínez-Colón, G. J., Smith, B. L., Rajendiran, T. M., & Núñez, G. (2013) · Immunity · doi:10.1016/j.immuni.2013.05.016 · Cited by 2,167
BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain
Coull, J. A. M., Beggs, S., Boudreau, D., Boivin, D., Tsuda, M., Inoue, K., Gravel, C., Salter, M. W., & De Koninck, Y. (2005) · Nature · doi:10.1038/nature04223 · Cited by 1,965
Ghiringhelli, F., Apetoh, L., Tesniere, A., Aymeric, L., Ma, Y., Ortiz, C., Vermaelen, K., Panaretakis, T., Mignot, G., Ullrich, E., et al. (2009) · Nature Medicine · doi:10.1038/nm.2028 · Cited by 1,898
The Cytolytic P 2Z Receptor for Extracellular ATP Identified as a P 2X Receptor (P2X 7 )
Surprenant, A., Rassendren, F., Kawashima, E., North, R. A., & Buell, G. (1996) · Science · doi:10.1126/science.272.5262.735 · Cited by 1,739
Physiology and Pathophysiology of Purinergic Neurotransmission
Burnstock, G. (2007) · Physiological Reviews · doi:10.1152/physrev.00043.2006 · Cited by 1,609
Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1
Dang, E. V., Barbi, J., Yang, H.-Y., Jinasena, D., Yu, H., Zheng, Y., Bordman, Z., Fu, J., Kim, Y., Yen, H.-R., et al. (2011) · Cell · doi:10.1016/j.cell.2011.07.033 · Cited by 1,595
P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury
Tsuda, M., Shigemoto‐Mogami, Y., Koizumi, S., Mizokoshi, A., Kohsaka, S., Salter, M. W., & Inoue, K. (2003) · Nature · doi:10.1038/nature01786 · Cited by 1,567
Understanding the mechanism of IL-1β secretion
Lopez-Castejon, G., & Brough, D. (2011) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2011.10.001 · Cited by 1,519
Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death
Casares, N., Pequignot, M. O., Tesniere, A., Ghiringhelli, F., Roux, S., Chaput, N., Schmitt, E., Hamai, A., Hervas-Stubbs, S., Obeid, M., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050915 · Cited by 1,512
NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux
He, Y., Zeng, M. Y., Yang, D., Motro, B., & Núñez, G. (2016) · Nature · doi:10.1038/nature16959 · Cited by 1,295
ATP drives lamina propria TH17 cell differentiation
Atarashi, K., Nishimura, J., Shima, T., Umesaki, Y., Yamamoto, M., Onoue, M., Yagita, H., Ishii, N., Evans, R., Honda, K., et al. (2008) · Nature · doi:10.1038/nature07240 · Cited by 1,089
The P2X7 Receptor: A Key Player in IL-1 Processing and Release
Ferrari, D., Pizzirani, C., Adinolfi, E., Lemoli, R. M., Curti, A., Idzko, M., Panther, E., & Di Virgilio, F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.7.3877 · Cited by 1,025
Nucleotide signalling during inflammation
Idzko, M., Ferrari, D., & Eltzschig, H. K. (2014) · Nature · doi:10.1038/nature13085 · Cited by 930
Altered Cytokine Production in Mice Lacking P2X7Receptors
Solle, M., Labasi, J. M., Perregaux, D. G., Stam, E. J., Petrushova, N., Koller, B. H., Griffiths, R., & Gabel, C. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006781200 · Cited by 924
Rapid Secretion of Interleukin-1β by Microvesicle Shedding
Mackenzie, A. B., Wilson, H. L., Kiss‐Toth, E., Dower, S., North, R. A., & Surprenant, A. (2001) · Immunity · doi:10.1016/s1074-7613(01)00229-1 · Cited by 862
Immune cell regulation by autocrine purinergic signalling
JUNGER, W. G. (2011) · Nature reviews. Immunology · doi:10.1038/nri2938 · Cited by 855
Human Monocytes Engage an Alternative Inflammasome Pathway
Gaidt, M. M., Ebert, T. S., Chauhan, D., Schmidt, T., Schmid-Burgk, J. L., Rapino, F. A., Robertson, A. A. B., Cooper, M. A., Graf, T., & Hornung, V. (2016) · Immunity · doi:10.1016/j.immuni.2016.01.012 · Cited by 808
Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain
Chessell, I. P., Hatcher, J. P., Bountra, C., Michel, A. D., Hughes, J. P., Green, P., Egerton, J., Murfin, M., Richardson, J. C., Peck, W. L., et al. (2005) · Pain · doi:10.1016/j.pain.2005.01.002 · Cited by 807
Purinergic regulation of the immune system
Cekic, C., & Linden, J. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.4 · Cited by 787
Perregaux, D. G., & Gabel, C. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36591-2 · Cited by 775
Crystal structure of the ATP-gated P2X4 ion channel in the closed state
Kawate, T., Michel, J. J. C., Birdsong, W. T., & Gouaux, E. (2009) · Nature · doi:10.1038/nature08198 · Cited by 739
Increased Level of Extracellular ATP at Tumor Sites: In Vivo Imaging with Plasma Membrane Luciferase
Pellegatti, P., Raffaghello, L., Bianchi, G., Piccardi, F., Pistoia, V., & Di Virgilio, F. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002599 · Cited by 668
Yang, D., He, Y., Muñoz-Planillo, R., Liu, Q., & Núñez, G. (2015) · Immunity · doi:10.1016/j.immuni.2015.10.009 · Cited by 622
Ferrari, D., Chiozzi, P., Falzoni, S., Susino, M. D., Melchiorri, L., Baricordi, O. R., & Virgilio, F. D. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.3.1451 · Cited by 616
Self-citationAcid sphingomyelinase activity triggers microparticle release from glial cells
Bianco, F., Perrotta, C., Novellino, L., Francolini, M., Riganti, L., Menna, E., Saglietti, L., Schuchman, E. H., Furlan, R., Clementi, E., et al. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.45 · Cited by 615
The IL-1 family and inflammatory diseases.
Dinarello, C. A. (2002) · PubMed · Cited by 597
Astrocyte-Derived ATP Induces Vesicle Shedding and IL-1β Release from Microglia
Bianco, F., Pravettoni, E., Colombo, A., Schenk, U., Möller, T., Matteoli, M., & Verderio, C. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.7268 · Cited by 596
Molecular mechanism of ATP binding and ion channel activation in P2X receptors
Hattori, M., & Gouaux, E. (2012) · Nature · doi:10.1038/nature11010 · Cited by 580
Extracellular purines, purinergic receptors and tumor growth
Virgilio, F. D., & Adinolfi, E. (2016) · Oncogene · doi:10.1038/onc.2016.206 · Cited by 567
Qu, Y., Franchi, L., Nunez, G., & Dubyak, G. R. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.3.1913 · Cited by 563
Programmed necrosis in inflammation: Toward identification of the effector molecules
Wallach, D., Kang, T., Dillon, C. P., & Green, D. R. (2016) · Science · doi:10.1126/science.aaf2154 · Cited by 555
A Primary Role for K+ and Na+ Efflux in the Activation of Apoptosis
Bortner, C. D., Hughes, F. M., & Cidlowski, J. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.51.32436 · Cited by 549
Activation and Regulation of Purinergic P2X Receptor Channels
Coddou, C., Yan, Z., Obšil, T., Huidobro-Toro, J. P., & Stojilković, S. S. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003129 · Cited by 520
Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-α
Mascanfroni, I. D., Takenaka, M. C., Yeste, A., Patel, B., Wu, Y., Kenison, J. E., Siddiqui, S., Basso, A. S., Otterbein, L. E., Pardoll, D. M., et al. (2015) · Nature Medicine · doi:10.1038/nm.3868 · Cited by 457
Neutrophil P2X7 receptors mediate NLRP3 inflammasome-dependent IL-1β secretion in response to ATP
Karmakar, M., Katsnelson, M. A., Dubyak, G. R., & Pearlman, E. (2016) · Nature Communications · doi:10.1038/ncomms10555 · Cited by 450
Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R
Wilhelm, K., Ganesan, J., Müller, T., Dürr, C., Grimm, M., Beilhack, A., Krempl, C. D., Sorichter, S., Gerlach, U. V., Jüttner, E., et al. (2010) · Nature Medicine · doi:10.1038/nm.2242 · Cited by 435
Elssner, A., Duncan, M., Gavrilin, M. A., & Wewers, M. D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.8.4987 · Cited by 425
The P2X7 Receptor Channel: Recent Developments and the Use of P2X7 Antagonists in Models of Disease
Bartlett, R., Stokes, L., & Sluyter, R. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008003 · Cited by 409
Lammas, D. A., Stober, C. B., Harvey, C. J., Kendrick, N., Panchalingam, S., & Kumararatne, D. S. (1997) · Immunity · doi:10.1016/s1074-7613(00)80364-7 · Cited by 393
Proteomic and functional evidence for a P2X7 receptor signalling complex
Kim, M., Jiang, L., Wilson, H. L., North, R. A., & Surprenant, A. (2001) · The EMBO Journal · doi:10.1093/emboj/20.22.6347 · Cited by 379
Oxidized ATP. An irreversible inhibitor of the macrophage purinergic P2Z receptor.
Murgia, M., Hanau, S., Pizzo, P., Rippa, M., & Virgilio, F. D. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53082-9 · Cited by 367
Mouse microglial cells express a plasma membrane pore gated by extracellular ATP
Ferrari, D., Villalba, M., Chiozzi, P., Falzoni, S., Ricciardi‐Castagnoli, P., & Virgilio, F. D. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.4.1531 · Cited by 352
Self-citationHuman astrocytes express a novel NLRP2 inflammasome
Minkiewicz, J., Vaccari, J. P. D. R., & Keane, R. W. (2013) · Glia · doi:10.1002/glia.22499 · Cited by 343
Mascanfroni, I. D., Yeste, A., Vieira, S. M., Burns, E. J., Patel, B., Sloma, I., Wu, Y., Mayo, L., Ben‐Hamo, R., Efroni, S., et al. (2013) · Nature Immunology · doi:10.1038/ni.2695 · Cited by 343
Woehrle, T., Yip, L., Elkhal, A., Sumi, Y., Chen, Y., Yao, Y., Insel, P. A., & JUNGER, W. G. (2010) · Blood · doi:10.1182/blood-2010-04-277707 · Cited by 331
Séman, M., Adriouch, S., Scheuplein, F., Krebs, C. F., Freese, D., Glowacki, G., Deterre, P., Haag, F., & Koch‐Nolte, F. (2003) · Immunity · doi:10.1016/s1074-7613(03)00266-8 · Cited by 330
Structural basis for subtype-specific inhibition of the P2X7 receptor
Karasawa, A., & Kawate, T. (2016) · eLife · doi:10.7554/elife.22153 · Cited by 322
Keystone, E. C., Wang, M. M., Layton, M., Hollis, S., & McInnes, I. B. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-143578 · Cited by 318
A Glu-496 to Ala Polymorphism Leads to Loss of Function of the Human P2X7 Receptor
Gu, B. J., Zhang, W., Worthington, R. A., Sluyter, R., Dao‐Ung, P., Petrou, S., Barden, J. A., & Wiley, J. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010353200 · Cited by 314
Schenk, U., Frascoli, M., Proietti, M., Geffers, R., Traggiai, E., Buer, J., Ricordi, C., Westendorf, A. M., & Grassi, F. (2011) · Science Signaling · doi:10.1126/scisignal.2001270 · Cited by 303
Niemi, K., Teirilä, L., Lappalainen, J., Rajamäki, K., Baumann, M. H., Öörni, K., Wolff, H., Kovanen, P. T., Matikainen, S., & Eklund, K. K. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002843 · Cited by 298
A Novel Recombinant Plasma Membrane-targeted Luciferase Reveals a New Pathway for ATP Secretion
Pellegatti, P., Falzoni, S., Pinton, P., Rizzuto, R., & Virgilio, F. D. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-03-0222 · Cited by 296
Self-citationActivation of Microglia by Amyloid β Requires P2X7 Receptor Expression
Sanz, J. M., Chiozzi, P., Ferrari, D., Colaianna, M., Idzko, M., Falzoni, S., Fellin, R., Trabace, L., & Di Virgilio, F. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803612 · Cited by 293
Self-citationExtracellular ATP mediates mast cell-dependent intestinal inflammation through P2X7 purinoceptors
Kurashima, Y., Amiya, T., Nochi, T., Fujisawa, K., Haraguchi, T., Iba, H., Tsutsui, H., Sato, S., Nakajima, S., Iijima, H., et al. (2012) · Nature Communications · doi:10.1038/ncomms2023 · Cited by 286
Beier, U. H., Angelin, A., Akimova, T., Wang, L., Liu, Y., Xiao, H., Koike, M. A., Hancock, S. A., Bhatti, T. R., Han, R., et al. (2015) · The FASEB Journal · doi:10.1096/fj.14-268409 · Cited by 282
Evolutionary origins of the purinergic signalling system
Burnstock, G., & Verkhratsky, A. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01957.x · Cited by 282
Stimulation of P2 receptors causes release of IL-1β–loaded microvesicles from human dendritic cells
Pizzirani, C., Ferrari, D., Chiozzi, P., Adinolfi, E., Sandonà, D., Savaglio, E., & Virgilio, F. D. (2006) · Blood · doi:10.1182/blood-2005-06-031377 · Cited by 280
Virgilio, F. D., Chiozzi, P., Falzoni, S., Ferrari, D., Sanz, J. M., Venketaraman, V., & Baricordi, O. R. (1998) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400341 · Cited by 278
Self-citationPotassium‐inhibited processing of IL‐1 beta in human monocytes.
Walev, I., Reske, K., Palmer, M., Valeva, A., & Bhakdi, S. C. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07149.x · Cited by 278
Ferrari, D., Łoś, M., Bauer, M. K. A., Vandenabeele, P., Wesselborg, S., & Schulze‐Osthoff, K. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00270-7 · Cited by 276
Adinolfi, E., Callegari, M. G., Ferrari, D., Bolognesi, C., Minelli, M., Wieckowski, M. R., Pinton, P., Rizzuto, R., & Virgilio, F. D. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-11-1025 · Cited by 272
X-ray structures define human P2X3 receptor gating cycle and antagonist action
Mansoor, S., Lü, W., Oosterheert, W., Shekhar, M., Tajkhorshid, E., & Gouaux, E. (2016) · Nature · doi:10.1038/nature19367 · Cited by 269
Reanalysis of P2X7Receptor Expression in Rodent Brain
Sim, J. A., Young, M. T., Sung, H.-Y., North, R. A., & Surprenant, A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1469-04.2004 · Cited by 264
Medicinal chemistry of adenosine, P2Y and P2X receptors
Jacobson, K. A., & Müller, C. E. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.12.001 · Cited by 262
ATP Acts as an Agonist to Promote Stimulus-Induced Secretion of IL-1β and IL-18 in Human Blood
Perregaux, D. G., McNiff, P. A., Laliberte, R., Conklyn, M. J., & Gabel, C. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.8.4615 · Cited by 256
Arulkumaran, N., Unwin, R. J., & Tam, F. W. K. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.578068 · Cited by 254
Trophic activity of a naturally occurring truncated isoform of the P2X7 receptor
Adinolfi, E., Cirillo, M., Woltersdorf, R., Falzoni, S., Chiozzi, P., Pellegatti, P., Callegari, M. G., Sandonà, D., Markwárdt, F., Schmalzing, G., et al. (2010) · The FASEB Journal · doi:10.1096/fj.09-153601 · Cited by 254
Self-citationATP induces nucleotide permeability in rat mast cells
Cockcroft, S., & Gomperts, B. D. (1979) · Nature · doi:10.1038/279541a0 · Cited by 251
Falzoni, S., Munerati, M., Ferrari, D., Spisani, S., Moretti, S., & Virgilio, F. D. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117770 · Cited by 249
Self-citationStock, T. C., Bloom, B. J., Wei, N., Ishaq, S., Park, W., WANG, X., Gupta, P. K., & MEBUS, C. A. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.110874 · Cited by 246
Molecular and functional properties of P2X receptors—recent progress and persisting challenges
Kaczmarek-Hájek, K., Lörinczi, É., Hausmann, R., & Nicke, A. (2012) · Purinergic Signalling · doi:10.1007/s11302-012-9314-7 · Cited by 237
Panenka, W. J., Jijon, H. B., Herx, L., Armstrong, J. N., Feighan, D., Wei, T., Yong, V. W., Ransohoff, R. M., & MacVicar, B. A. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-18-07135.2001 · Cited by 234
Nucleoside reverse transcriptase inhibitors possess intrinsic anti-inflammatory activity
Fowler, B. J., Gelfand, B. D., Kim, Y., Kerur, N., Tarallo, V., Hirano, Y., Amarnath, S., Fowler, D. H., Radwan, M., Young, M. T., et al. (2014) · Science · doi:10.1126/science.1261754 · Cited by 225
The P2X7 receptor directly interacts with the NLRP3 inflammasome scaffold protein
Franceschini, A., Capece, M., Chiozzi, P., Falzoni, S., Sanz, J. M., Sarti, A. C., Bonora, M., Pinton, P., & Di Virgilio, F. (2015) · The FASEB Journal · doi:10.1096/fj.14-268714 · Cited by 225
Self-citationBasso, A. M., Bratcher, N. A., Harris, R. R., Jarvis, M. F., Decker, M. W., & Rueter, L. E. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.10.018 · Cited by 224
Activation of NLRP3 and AIM2 Inflammasomes by Porphyromonas gingivalis Infection
Park, E.-J., Na, H. S., Song, Y., Shin, S. Y., Kim, Y., & Chung, J. (2013) · Infection and Immunity · doi:10.1128/iai.00862-13 · Cited by 224
Extracellular NAD+ shapes the Foxp3+ regulatory T cell compartment through the ART2–P2X7 pathway
Hubert, S., Rissiek, B., Klages, K., Huehn, J., Sparwasser, T. D., Haag, F., Koch‐Nolte, F., Boyer, O., Séman, M., & Adriouch, S. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20091154 · Cited by 215
Increased Proliferation Rate of Lymphoid Cells Transfected with the P2X7 ATP Receptor
Baricordi, O. R., Melchiorri, L., Adinolfi, E., Falzoni, S., Chiozzi, P., Buell, G. N., & Virgilio, F. D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.47.33206 · Cited by 212
Self-citationIdentification and characterization of splice variants of the human P2X7 ATP channel
Cheewatrakoolpong, B., Gilchrest, H., Anthes, J. C., & Greenfeder, S. A. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.04.087 · Cited by 207
He, Y., Franchi, L., & Núñez, G. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1202737 · Cited by 206
The human P2X7 receptor and its role in innate immunity
Wiley, J. S., Sluyter, R., Gu, B. J., Stokes, L., & Fuller, S. J. (2011) · Tissue Antigens · doi:10.1111/j.1399-0039.2011.01780.x · Cited by 198
P2X7 receptor regulation of non-classical secretion from immune effector cells
Dubyak, G. (2012) · Cellular Microbiology · doi:10.1111/cmi.12001 · Cited by 197
Extracellular ATP4- promotes cation fluxes in the J774 mouse macrophage cell line.
Steinberg, T. H., & Silverstein, S. C. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61477-2 · Cited by 196
Amoroso, F., Capece, M., Rotondò, A., Cangelosi, D., Ferracin, M., Franceschini, A., Raffaghello, L., Pistoia, V., Varesio, L., & Adinolfi, E. (2015) · Oncogene · doi:10.1038/onc.2014.444 · Cited by 194
Nanobodies that block gating of the P2X7 ion channel ameliorate inflammation
Danquah, W., Meyer‐Schwesinger, C., Rissiek, B., Pinto, C., Prat, A. S., Amadi, M., Iacenda, D., Knop, J., Hammel, A., Bergmann, P., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf8463 · Cited by 191
Fc receptor-mediated phagocytosis occurs in macrophages at exceedingly low cytosolic Ca2+ levels.
Virgilio, F. D., Meyer, B. C., Greenberg, S., & Silverstein, S. C. (1988) · The Journal of Cell Biology · doi:10.1083/jcb.106.3.657 · Cited by 190
Humphreys, B. D., & Dubyak, G. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.12.5627 · Cited by 189
Nicke, A., Kuan, Y., Masin, M., Rettinger, J., Marquez-Klaka, B., Bender, O., Górecki, D. C., Murrell‐Lagnado, R. D., & Soto, F. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.033134 · Cited by 187
An ATP-activated channel is involved in mitogenic stimulation of human T lymphocytes
Baricordi, O., Ferrari, D., Melchiorri, L., Chiozzi, P., Hanau, S., Chiari, E., Rubini, M., & Virgilio, F. D. (1996) · Blood · doi:10.1182/blood.v87.2.682.bloodjournal872682 · Cited by 185
Verkhratsky, A., & Burnstock, G. (2014) · BioEssays · doi:10.1002/bies.201400024 · Cited by 185
Denlinger, L. C., Fisette, P. L., Sommer, J. A., Watters, J. J., Prabhu, U., Dubyak, G., Proctor, R. A., & Bertics, P. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.4.1871 · Cited by 182
Proietti, M., Cornacchione, V., Rezzonico Jost, T., Romagnani, A., Faliti, C. E., Perruzza, L., Rigoni, R., Radaelli, E., Caprioli, F., Preziuso, S., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.10.010 · Cited by 181
Shieh, C., Heinrich, A., Serchov, T., van Calker, D., & Biber, K. (2014) · Glia · doi:10.1002/glia.22628 · Cited by 179
Accelerated Tumor Progression in Mice Lacking the ATP Receptor P2X7
Adinolfi, E., Capece, M., Franceschini, A., Falzoni, S., Giuliani, A. L., Rotondo, A., Sarti, A. C., Bonora, M., Syberg, S., Corigliano, D. M., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1259 · Cited by 177
Self-citationBoué‐Grabot, É., Archambault, V., & Séguéla, P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.10190 · Cited by 175
Virgilio, F. D., Bronte, V., Collavo, D., & Zanovello, P. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.6.1955 · Cited by 175
Panupinthu, N., Rogers, J. T., Zhao, L., Solano-Flores, L. P., Possmayer, F., Sims, S. M., & Dixon, S. J. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200708037 · Cited by 175
Pseudoapoptosis Induced by Brief Activation of ATP-gated P2X7 Receptors
Mackenzie, A. B., Young, M. T., Adinolfi, E., & Surprenant, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502705200 · Cited by 174
Stokes, L., Fuller, S. J., Sluyter, R., Skarratt, K. K., Gu, B. J., & Wiley, J. S. (2010) · The FASEB Journal · doi:10.1096/fj.09-150862 · Cited by 174
Ferrari, D., Sala, A. L., Chiozzi, P., Morelli, A., Falzoni, S., Girolomoni, G., Idzko, M., Dichmann, S., Norgauer, J., & Virgilio, F. D. (2000) · The FASEB Journal · doi:10.1096/fj.00-0031com · Cited by 173
Self-citationThe Therapeutic Potential of Modifying Inflammasomes and NOD-Like Receptors
Virgilio, F. D. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.006171 · Cited by 168
Cabrini, G., Falzoni, S., Forchap, S., Pellegatti, P., Balboni, A., Agostini, P., Cuneo, A., Castoldi, G., Baricordi, O. R., & Virgilio, F. D. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.82 · Cited by 164
Self-citationKerur, N., Hirano, Y., Tarallo, V., Fowler, B. J., Bastos-Carvalho, A., Yasuma, T. R., Yasuma, R., Kim, Y., Hinton, D. R., Kirschning, C. J., et al. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-12500 · Cited by 163
Feng, Y., Li, X., Wang, L., Zhou, L., & Gorodeski, G. I. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602999200 · Cited by 162
Rapid ATP-induced release of matrix metalloproteinase 9 is mediated by the P2X7 receptor
Gu, B. J., & Wiley, J. S. (2006) · Blood · doi:10.1182/blood-2005-07-2994 · Cited by 160
Solini, A., Chiozzi, P., Morelli, A., Fellin, R., & Virgilio, F. D. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.3.297 · Cited by 159
Tomasinsig, L., Pizzirani, C., Skerlavaj, B., Pellegatti, P., Gulinelli, S., Tossi, A., Virgilio, F. D., & Zanetti, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802185200 · Cited by 158
Zanovello, P., Bronte, V., Rosato, A., Pizzo, P., & Virgilio, F. D. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.5.1545 · Cited by 158
Gu, B. J., Bendall, L. J., & Wiley, J. S. (1998) · Blood · doi:10.1182/blood.v92.3.946 · Cited by 157
Inhibition of Chlamydial Infectious Activity due to P2X7R-Dependent Phospholipase D Activation
Coutinho‐Silva, R., Welter-Stahl, L., Raymond, M., Jungas, T., Verbeke, P., Burnstock, G., Darville, T. L., & Ojcius, D. M. (2003) · Immunity · doi:10.1016/s1074-7613(03)00235-8 · Cited by 157
The P2X7 receptor is a key modulator of aerobic glycolysis
Amoroso, F., Falzoni, S., Adinolfi, E., Ferrari, D., & Virgilio, F. D. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.105 · Cited by 157
Self-citationP2X7 receptor activation induces CXCL2 production in microglia through NFAT and PKC/MAPK pathways
Shiratori, M., Tozaki‐Saitoh, H., Yoshitake, M., Tsuda, M., & Inoue, K. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06809.x · Cited by 153 · cited 1×
“…and mouse mast cells (Panenka et al., 2001; Kurashima et al., 2012), IL-8 in rat C6 glioma cells (Wei et al., 2008), CC-chemokine ligand 3 (CCL3) in mouse microglial MG-5 cells (Kataoka et al., 2009), and CXCL2 in mouse microglia and mast cells (Shiratori et al., 2010; Kurashima et al., 2012).”
El-Moatassim, C., & Dubyak, G. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35890-3 · Cited by 153
P2X7 Receptor Channels Allow Direct Permeation of Nanometer-Sized Dyes
Browne, L. E., Compan, V., Bragg, L., & North, R. A. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2235-12.2013 · Cited by 151
Gu, B. J., Bendall, L. J., & Wiley, J. S. (1998) · Blood · doi:10.1182/blood.v92.3.946.415a24_946_951 · Cited by 148
Significance of P2X7 Receptor Variants to Human Health and Disease
Sluyter, R., & Stokes, L. (2011) · Recent Patents on DNA & Gene Sequences · doi:10.2174/187221511794839219 · Cited by 147
Sung, S. S., Young, J. D., Origlio, A. M., Heiple, J. M., Kaback, H. R., & Silverstein, S. C. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38740-9 · Cited by 145
Gu, B. J., Sluyter, R., Skarratt, K. K., Shemon, A. N., Dao‐Ung, L., Fuller, S. J., Barden, J. A., Clarke, A. L., Petrou, S., & Wiley, J. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313902200 · Cited by 145
Csóka, B., Németh, Z. H., Törő, G., Idzko, M., Zech, A., Koscsó, B., Spolarics, Z., Antonioli, L., Cseri, K., Erdélyi, K., et al. (2015) · The FASEB Journal · doi:10.1096/fj.15-272450 · Cited by 142
The secretion of IL-1β and options for release
Piccioli, P., & Rubartelli, A. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.10.007 · Cited by 142
The Role of the P2X7 Receptor in Infectious Diseases
Miller, C., Boulter, N. R., Fuller, S. J., Zakrzewski, A. M., Lees, M. P., Saunders, B. M., Wiley, J. S., & Smith, N. C. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002212 · Cited by 142
P2X7 receptor‐stimulation causes fever via PGE2 and IL‐1β release
Barberà‐Cremades, M., Baroja‐Mazo, A., Gomez, A. I., Machado, F., Di Virgilio, F., & Pelegrín, P. (2012) · The FASEB Journal · doi:10.1096/fj.12-205765 · Cited by 142
Eser, A., Colombel, J., Rutgeerts, P. J., Vermeire, S., Vogelsang, H., Braddock, M., Persson, T., & Reinisch, W. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000514 · Cited by 138
Territo, P. R., Meyer, J. A., Peters, J. S., Riley, A. K., McCarthy, B. P., Gao, M., Wang, M., Green, M. A., Zheng, Q., & Hutchins, G. D. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.181354 · Cited by 138
Resta, V., Novelli, E., Vozzi, G., Scarpa, C., Caleo, M., Ahluwalia, A. D., Solini, A., Santini, E., Parisi, V., Virgilio, F. D., et al. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05528.x · Cited by 137
ATP/P2X7 axis modulates myeloid-derived suppressor cell functions in neuroblastoma microenvironment
Bianchi, G., Vuerich, M., Pellegatti, P., Marimpietri, D., Emionite, L., Marigo, I., Bronte, V., Virgilio, F. D., Pistoia, V., & Raffaghello, L. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.109 · Cited by 131
Genetics of the P2X7 receptor and human disease
Fuller, S. J., Stokes, L., Skarratt, K. K., Gu, B. J., & Wiley, J. S. (2009) · Purinergic Signalling · doi:10.1007/s11302-009-9136-4 · Cited by 125
Kataoka, A., Tozaki‐Saitoh, H., Koga, Y., Tsuda, M., & Inoue, K. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05744.x · Cited by 121
P2X7 Receptor as a Therapeutic Target
Marchi, E. D., Orioli, E., Ben, D. D., & Adinolfi, E. (2016) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2015.11.004 · Cited by 117
ATP-Induced Inflammation Drives Tissue-Resident Th17 Cells in Metabolically Unhealthy Obesity
Pandolfi, J. B., Ferraro, A., Sananez, I., Gancedo, M. C., Baz, P., Billordo, L. A., Fainboim, L., & Arruvito, L. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502506 · Cited by 115
Astrocyte-Mediated Ischemic Tolerance
Hirayama, Y., Ikeda‐Matsuo, Y., Notomi, S., Enaida, H., Kinouchi, H., & Koizumi, S. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.4218-14.2015 · Cited by 114
Jiang, L., Baldwin, J. M., Roger, S., & Baldwin, S. A. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00055 · Cited by 114
Masin, M., Young, C., Lim, K., Barnes, S. J., Xu, X., Marschall, V., Brutkowski, W., Mooney, E. R., Górecki, D. C., & Murrell‐Lagnado, R. D. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01624.x · Cited by 112
Killeen, M. E., Ferris, L. K., Kupetsky, E. A., Falo, L. D., & Mathers, A. R. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202045 · Cited by 111
Long-Term Heart Transplant Survival by Targeting the Ionotropic Purinergic Receptor P2X7
Vergani, A., Tezza, S., D’Addio, F., Fotino, C., Liu, K., Niewczas, M. A., Bassi, R., Molano, R. D., Kleffel, S., Petrelli, A., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.123653 · Cited by 108
Gilbert, S. M., Baird, A. G., Glazer, S., Barden, J. A., Glazer, A., Teh, L. C., & King, J. (2017) · British Journal of Dermatology · doi:10.1111/bjd.15364 · Cited by 104
On the permeation of large organic cations through the pore of ATP-gated P2X receptors
Harkat, M., Peverini, L., Cerdan, A. H., Dunning, K., Beudez, J., Martz, A., Calimet, N., Specht, A., Cecchini, M., Chataigneau, T., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1701379114 · Cited by 104
Roger, S., Jelassi, B., Couillin, I., Pelegrín, P., Besson, P., & Jiang, L. (2014) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.10.029 · Cited by 103
Jimenez-Mateos, E. M., Arribas-Blazquez, M., Sanz-Rodriguez, A., Concannon, C., Olivos-Ore, L. A., Reschke, C. R., Mooney, C. M., Mooney, C., Lugara, E., Morgan, J., et al. (2015) · Scientific Reports · doi:10.1038/srep17486 · Cited by 103
Baroni, M., Pizzirani, C., Pinotti, M., Ferrari, D., Adinolfi, E., Calzavarini, S., Caruso, P., Bernardi, F., & Virgilio, F. D. (2007) · The FASEB Journal · doi:10.1096/fj.06-7238com · Cited by 101
Amaral, E. P., Ribeiro, S. C. M., Lanes, V. R., Almeida, F. M., de Andrade, M. R. M., Bomfim, C. C. B., de Salles, É. M., Bortoluci, K. R., Coutinho‐Silva, R., Hirata, M. H., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004188 · Cited by 99
P2X7 Receptors Regulate NKT Cells in Autoimmune Hepatitis
Kawamura, H., Aswad, F., Minagawa, M., Govindarajan, S., & Dennert, G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.4.2152 · Cited by 98
Alzola, E., Pérez-Etxebarria, A., Kabré, E., Fogarty, D. J., Métioui, M., Chaı̈b, N., Macarulla, J. M., Matute, C., Dehaye, J., & Marino, A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.46.30208 · Cited by 98
BRADFORD, M. D., & Soltoff, S. P. (2002) · Biochemical Journal · doi:10.1042/bj20020358 · Cited by 97
Expression and function of the P2X7 receptor in rat C6 glioma cells
Wei, W., Ryu, J. K., Choi, H. B., & McLarnon, J. G. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.10.025 · Cited by 96
Ory, D., Celen, S., Gijsbers, R., den Haute, C. V., Postnov, A. A., Koole, M. J. B., Vandeputte, C., Andrés, J.-I., Alcázar, J., Angelis, M. D., et al. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.169995 · Cited by 96
P2X7 receptor antagonists: a patent review (2010–2015)
Park, J.-H., & Kim, Y. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2017.1246538 · Cited by 92
The Antibiotic Polymyxin B Modulates P2X7 Receptor Function
Ferrari, D., Pizzirani, C., Adinolfi, E., Forchap, S., Sitta, B., Turchet, L., Falzoni, S., Minelli, M., Baricordi, R., & Virgilio, F. D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.7.4652 · Cited by 91
Self-citationCoutinho‐Silva, R., & Ojcius, D. M. (2012) · Microbes and Infection · doi:10.1016/j.micinf.2012.05.009 · Cited by 91
Ali, S. R., Timmer, A. M., Bilgrami, S., Park, E. J., Eckmann, L., Nizet, V., & Karin, M. (2011) · Immunity · doi:10.1016/j.immuni.2011.04.015 · Cited by 84
Jørgensen, N. R., Husted, L. B., Skarratt, K. K., Stokes, L., Tofteng, C. L., Kvist, T., Jensen, J. B., Eiken, P., Brixen, K., Fuller, S. J., et al. (2012) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.253 · Cited by 82
Localization of the gate and selectivity filter of the full-length P2X7 receptor
Pippel, A., Stolz, M., Woltersdorf, R., Kless, A., Schmalzing, G., & Markwárdt, F. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1610414114 · Cited by 81
The trafficking and targeting of P2X receptors
Robinson, L. E., & Murrell‐Lagnado, R. D. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00233 · Cited by 80
Mortimer, L. M., Moreau, F., Cornick, S., & Chadee, K. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004887 · Cited by 79
P2X purinergic receptor ligands: recently patented compounds
Gunosewoyo, H., & Kassiou, M. (2010) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543771003702424 · Cited by 78
Is pannexin the pore associated with the P2X7 receptor?
Alberto, A. V. P., Faria, R. X., Couto, C. G. C., Ferreira, L. G. B., Souza, C. A. M., Teixeira, P. C. N., Fróes, M. M., & Alves, L. A. (2013) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-013-0868-x · Cited by 78
Structural Insights into Divalent Cation Modulations of ATP-Gated P2X Receptor Channels
Kasuya, G., Fujiwara, Y., Takemoto, M., Dohmae, N., Nakada-Nakura, Y., Ishitani, R., Hattori, M., & Nureki, O. (2016) · Cell Reports · doi:10.1016/j.celrep.2015.12.087 · Cited by 78
Graziano, F., Desdouits, M., Garzetti, L., Podini, P., Alfano, M., Rubartelli, A., Furlan, R., Benaroch, P., & Poli, G. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1500656112 · Cited by 77
Taylor, S. R. J., González–Begne, M., Dewhurst, S., Chimini, G., Higgins, C. F., Melvin, J. E., & Elliott, J. I. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.1.300 · Cited by 75
P2X7 Receptor Modulates Inflammatory and Functional Pulmonary Changes Induced by Silica
Monção-Ribeiro, L. C., Faffe, D. S., Santana, P. T., Vieira, F. S., da Graça, C. L. A. L., Marques-da-Silva, C., Machado, M. N., Caruso-Neves, C., Zin, W. A., Borojevic, R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110185 · Cited by 71
Shenker, B. J., Ojcius, D. M., Walker, L. M., Zekavat, A., Scuron, M. D., & Boesze‐Battaglia, K. (2015) · Infection and Immunity · doi:10.1128/iai.03132-14 · Cited by 70
Sinadinos, A., Young, C., Al-khalidi, R. A. A., Teti, A. M., Kaliński, P., Mohamad, S., Floriot, L., Henry, T., Tozzi, G., Jiang, T., et al. (2015) · PLoS Medicine · doi:10.1371/journal.pmed.1001888 · Cited by 65
Karki, P., Seong, C. M., Kim, J.-E., Hur, K., Shin, S. Y., Lee, J. S., Cho, B. C., & Is, P. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402221 · Cited by 65
Perregaux, D. G., & Gabel, C. A. (1998) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1998.275.6.c1538 · Cited by 63
Fantoni, E., Ben, D. D., Falzoni, S., Virgilio, F. D., Lovestone, S., & Gee, A. D. (2017) · EJNMMI Research · doi:10.1186/s13550-017-0275-2 · Cited by 63
Self-citationExploring the ATP-binding site of P2X receptors
Chataigneau, T., Lemoine, D. G., & Grütter, T. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00273 · Cited by 61
Sun, C., Chu, J., Singh, S. G., & Salter, R. D. (2009) · Purinergic Signalling · doi:10.1007/s11302-009-9168-9 · Cited by 58
Maître, B., Magnenat, S., Heim, V., Ravanat, C., Evans, R. J., de la Salle, H., Gachet, C., & Hechler, B. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401786 · Cited by 57
P2X7 and phospholipid signalling: The search of the “missing link” in epithelial cells
Garcia‐Marcos, M., Pochet, S., Marino, A., & Dehaye, J. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.05.008 · Cited by 56
Fan, Z., Zhang, Y., Yi-hong, G., Huang, N., Ma, H., Huang, H., & Yu, H. (2016) · Scientific Reports · doi:10.1038/srep35804 · Cited by 56
Rissiek, B., Danquah, W., Haag, F., & Koch‐Nolte, F. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0713407 · Cited by 55
Quantifying Ca2+ Current and Permeability in ATP-gated P2X7 Receptors
Liang, X., Samways, D. S. K., Wolf, K. J., Bowles, E. A., Richards, J. P., Bruno, J., Dutertre, S., DiPaolo, R. J., & Egan, T. M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.627810 · Cited by 54
Contraction of intestinal effector T cells by retinoic acid-induced purinergic receptor P2X7
Hashimoto‐Hill, S., Friesen, L., Kim, M., & Kim, C. H. (2016) · Mucosal Immunology · doi:10.1038/mi.2016.109 · Cited by 54
Ledderose, C., Woehrle, T., Ledderose, S., Strasser, K., Seist, R., Bao, Y., Zhang, J., & JUNGER, W. G. (2016) · Purinergic Signalling · doi:10.1007/s11302-016-9510-y · Cited by 50
Lymphocytes from P2X7-deficient mice exhibit enhanced P2X7 responses
Taylor, S. R. J., González–Begne, M., Sojka, D. K., Richardson, J. C., Sheardown, S. A., Harrison, S. M., Pusey, C. D., Tam, F. W. K., & Elliott, J. I. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0408251 · Cited by 49
P2 receptor blockade attenuates fever and cytokine responses induced by lipopolysaccharide in rats
Gourine, A. V., Poputnikov, D. M., Zhernosek, N., Melenchuk, E. V., Gerstberger, R., Spyer, K. M., & Gourine, V. N. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706287 · Cited by 48
Lenertz, L. Y., Wang, Z., Guadarrama, A. G., Hill, L. M., Gavala, M. L., & Bertics, P. J. (2010) · Biochemistry · doi:10.1021/bi902083n · Cited by 47
Ledderose, C., Bao, Y., Ledderose, S., Woehrle, T., Heinisch, M., Yip, L., Zhang, J., Robson, S. C., Shapiro, N. I., & JUNGER, W. G. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv373 · Cited by 47
Exogenous ATP enhances calcium influx in intact thymocytes.
Lin, J. H.-C., Krishnaraj, R., & Kemp, R. G. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.5.3403 · Cited by 45
Purinergic P2X receptors: Structural models and analysis of ligand-target interaction
Ben, D. D., Buccioni, M., Lambertucci, C., Marucci, G., Thomas, A., & Volpini, R. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.10.071 · Cited by 45
Barberà-Cremades, M., Baroja‐Mazo, A., & Pelegrı́n, P. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.1a0514-267rr · Cited by 43
Norde, W. J., Overes, I. M., Maas, F., Fredrix, H., Vos, J. C. M., Kester, M. G. D., van der Voort, R., Jedema, I., Falkenburg, J. H. F., Schattenberg, A. V. M. B., et al. (2008) · Blood · doi:10.1182/blood-2008-04-153825 · Cited by 42
Omosun, Y., McKeithen, D. N., Ryans, K., Kibakaya, C., Blas‐Machado, U., Li, D., Singh, R., Inoue, K., Xiong, Z.-G., Eko, F. O., et al. (2015) · Infection and Immunity · doi:10.1128/iai.00993-15 · Cited by 41
Genetic Background Strongly Influences the Bone Phenotype of P2X7 Receptor Knockout Mice
Syberg, S., Petersen, S., Jensen, J. B., Gartland, A., Teilmann, J., Chessell, I. P., Steinberg, T. H., Schwarz, P., & Jørgensen, N. R. (2012) · Journal of Osteoporosis · doi:10.1155/2012/391097 · Cited by 41
Baconguis, I., Hattori, M., & Gouaux, E. (2013) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2013.04.005 · Cited by 36
Rizzo, R., Ferrari, D., Melchiorri, L., Stignani, M., Gulinelli, S., Baricordi, O. R., & Virgilio, F. D. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804265 · Cited by 34
Murine macrophage P2X7 receptors support rapid prothrombotic responses
Moore, S., & Mackenzie, A. B. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.10.010 · Cited by 33
A Truncation Variant of the Cation Channel P2RX5 Is Upregulated during T Cell Activation
Abramowski, P., Ogrodowczyk, C., Martinꝉ, R., & Pongs, O. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104692 · Cited by 30
Munerati, M., Cortesi, R., Ferrari, D., Virgilio, F. D., & Nastruzzi, C. (1994) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(94)90200-3 · Cited by 29
Laliberte, R. E., Perregaux, D. G., McNiff, P. A., & Gabel, C. A. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.62.2.227 · Cited by 26
Cited by
Sorted by citations
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
Gong, T., Liu, L., Jiang, W., & Zhou, R. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0215-7 · Cited by 1,672
Role of neuroinflammation in neurodegeneration development
Zhang, W., Xiao, D., Mao, Q., & Xia, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01486-5 · Cited by 1,668
Targeting the NLRP3 inflammasome in inflammatory diseases
Mangan, M. S. J., Olhava, E. J., Roush, W. R., Seidel, H. M., Glick, G. D., & Latz, E. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.97 · Cited by 1,885
Inflammation and atherosclerosis: signaling pathways and therapeutic intervention
Kong, P., Cui, Z.-Y., Huang, X.-F., Zhang, D.-D., Guo, R.-J., & Han, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00955-7 · Cited by 1,183
Pyroptosis versus necroptosis: similarities, differences, and crosstalk
Frank, D., & Vince, J. E. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-018-0212-6 · Cited by 1,062
Metadata
- Authors
- Di Virgilio, F., Dal Ben, D., Sarti, A. C., Giuliani, A. L., & Falzoni, S.
- Affiliations
- University of Ferrara (IT)
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2017-07
- Volume
- 47
- Issue
- 1
- Pages
- 15-31
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W2737555531
- Cited by
- 1,267
- References
- 199
- Citations by year
- 2026: 167 · 2025: 138 · 2024: 164 · 2023: 155 · 2022: 160 · 2021: 161 · 2020: 132 · 2019: 102 · 2018: 78 · 2017: 9
- FWCI
- 9.14
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Immunity (publishedVersion)
- PubMed (publishedVersion)
- Unicam Scientific Publications (University of Camerino) (submittedVersion, other-oa)
- Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion, cc-by)
- Funders
- Italian Association for Cancer Research (IG 13025, IG 18581)
- Telethon of Italy (GGP06070)
- ERA-NET Neuron Joint Transnational Project “Nanostroke,” the Ministry of Health of Italy (RF-2011-02348435)
- Italian Ministry of Education, University and Research (RBAP11FXBC_001)
- University of Ferrara
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- P2X7 receptor, extracellular ATP, purinergic receptors, NLRP3 inflammasome, inflammation, innate immunity, adaptive immunity, cytokine and chemokine secretion, single nucleotide polymorphisms, cancer, anti-inflammatory therapy, cancer therapy, signal transduction, receptor structure
- MeSH terms
- Animals, Cell Differentiation, Humans, Infections, Inflammation, Macrophages, T-Lymphocytes, Receptors, Purinergic P2X7, Inflammasomes, Purinergic P2X Receptor Agonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
